Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 5/20 | 0.48 |
| ▸ | PDE4A | P27815 | 4/20 | 0.48 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | GCGR | P47871 | 1/20 | 0.37 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.36 |
| ▸ | USP7 | Q93009 | 2/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17580697 | 0.83 | PDE4B (0.44) | PDE4BPDE4APDE4CPDE4DCNR2 | |
| SCHEMBL27530678 | 0.80 | SOAT1 (0.40) | PDE4BPDE4APDE4CPDE4DCNR2 | |
| SCHEMBL28139838 | 0.79 | CNR2 (0.49) | PDE4BPDE4APDE4CPDE4DCNR2 | |
| SCHEMBL18138370 | 0.77 | SOAT1 (0.36) | PDE4BPDE4APDE4CPDE4DCNR2 | |
| SCHEMBL9788120 | 0.76 | GCGR (0.46) | CNR2KDM4EMAPTSOAT1GCGR | |
| SCHEMBL5590089 | 0.73 | NR5A1 (0.44) | NR5A1ALOX5LTA4H | |
| SCHEMBL5587773 | 0.73 | NR5A1 (0.44) | NR5A1ALOX5LTA4H | |
| SCHEMBL5588266 | 0.73 | NR5A1 (0.44) | NR5A1ALOX5LTA4H | |
| SCHEMBL5588674 | 0.73 | NR5A1 (0.44) | NR5A1ALOX5LTA4H | |
| SCHEMBL5589121 | 0.73 | NR5A1 (0.44) | NR5A1ALOX5LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765688-B2 | Anti-dandruff compositions containing peptides | BASF SE (DE) | 2014-07-01 | — | — | US | disclosed |
| US-20100310644-A1 | ANTI-DANDRUFF COMPOSITIONS CONTAINING PEPTIDES | BASF ,Trademarks and Licenses (DE) | 2010-12-09 | — | — | US | disclosed |
| US-20080193405-A1 | Use of a Water-In-Water Emulsion Polymers in the Form of a Thickener for Cosmetic Preparations | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20050189377-A1 | Dispenser and cosmetic or dermatological preparation comprising an auxiliary for use with dispenser | BEIERSDORF AG | 2005-09-01 | — | — | US | disclosed |
| US-20050169855-A1 | Cosmetic and dermatological light protection formulations | BEIERSDORF AG | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193405-A1 | Use of a Water-In-Water Emulsion Polymers in the Form of a Thickener for Cosmetic Preparations | POLH, POLR1C, POLQ | PDE4B 4630/4885PDE4A 4492/4885PDE4C 4341/4885 |
| US-20050169855-A1 | Cosmetic and dermatological light protection formulations | USP30, CD63, TYR | PDE4B 4713/4885PDE4A 4685/4885PDE4C 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.